Hippo 1-for-25 Reverse Stock Split to Become Effective at 11:59 p.m. EDT September 29, 2022 Palo Alto, Business
Exai Bio Presents Data Demonstrating that its Novel RNA-based Liquid Biopsy Platform has Potential for Early Detection and Monitoring of Colorectal Cancer Palo Alto, Business
Jiya Acquisition Corp. Receives NASDAQ Notification of Non-Compliance With Listing Rules Palo Alto, Business
Ken Moore Begins as New Chair of the Gordon and Betty Moore Foundation Board of Trustees Palo Alto, Business
Hippo Welcomes Insurance Industry Leader John 'Jay' Nichols Jr. to Board of Directors Palo Alto, Business
ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension Palo Alto, Business
High Rates of Chronic Hepatitis B and Tuberculosis Co-Infection Observed in Nationally Representative Quest Diagnostics Study Palo Alto, Business
Databook Accelerates Business Momentum with Record Hiring, Revenue Growth, and Expansion Palo Alto, Business